Radnostix INIS
OTC INIS
$0.05 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Radnostix (INIS) Gains from Equity Investments (2011 - 2013)

Updated

Analysis

Radnostix (INIS) Gains from Equity Investments (2011 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 Radnostix 23.81 Mn 17.92 Mn 1.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 -2,746.00
Dec 31, 2012 -8,538.00
Sep 30, 2012 -13,943.00
Jun 30, 2012 -5,206.00
Mar 31, 2012 -26,776.00
Dec 31, 2011 -21,945.00
Sep 30, 2011 -43,451.00
Jun 30, 2011 -31,390.00
Mar 31, 2011 -44,856.00
API Access

Radnostix Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=INIS&period=max&api_key=YOUR_API_KEY